Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 5,370.20 Million |
| USD 8,920.90 Million | |
| % | |
|
Global Diabetes Treatments Market, By Type of Diabetes (Type-1, Type-2), Product (Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs), Devices (Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic) - Industry Trends and Forecast to 2030.
The increasing prevalence of diabetes and technological advancements in innovative diabetes treatments have significantly improved the design and functionality of the diabetes treatments market and have carved the way for the growth of the diabetes treatments market. The market for diabetes treatment has been growing steadily due to several factors. Firstly, rising healthcare expenditure has been a driver in the market. In addition, an increasing geriatric population contributes to the market for diabetes treatments market.
Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of the diabetes treatments market owing to the advancements in technology that have led to the development of advancements diabetes treatment for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customisable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type of Diabetes (Type-1, Type-2), Product (Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs), Devices (Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic),
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Roche Products Limited (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Sanofi-Deutschland GmbH (Germany), Novo Nordisk A/S (Germany), ARKRAY USA, Inc. (U.S.), Bayer AG (U.S.), Amylin Pharmaceuticals Inc. (U.S.), Abbott (U.S.), Medtronic Inc. (U.S.), Teva Pharmaceuticals Pvt Ltd.(U.S.), Home Diagnostics Inc. (U.S.), Novartis AG. (U.S.), Eli Lilly and Company. (U.S.), Merck & Co., Inc, .(U.S.), AstraZeneca (U.K.), Boehringer Ingelheim International GmbH (Germany), Takeda Pharmaceutical Company Limited (Japan)
|
|
Market Opportunities
|
|
Market Definition
The global diabetes treatments market refers to the market for products, medications, devices, and therapies used to treat and manage diabetes. Diabetes is a chronic medical condition characterized by high blood sugar levels resulting from the body's inability to produce or effectively use insulin, a hormone responsible for regulating blood glucose levels.
Drivers
The rising prevalence of diabetes worldwide is a significant driver for the market. The disease is reaching epidemic proportions due to sedentary lifestyles, unhealthy diets, and an aging population. As the number of people with diabetes grows, the demand for effective treatments and management options increases.
Increased awareness about diabetes and its complications has driven the demand for diabetes treatments. Education campaigns and initiatives by healthcare organizations, governments, and patient advocacy groups have led to earlier diagnosis, better management practices, and increased demand for effective treatment options.
Advances in medical technology have led to the development of innovative diabetes treatments. Continuous glucose monitoring systems, insulin pumps, and other devices have improved the management of diabetes and enhance patient outcomes. Technological advancements continue to drive the market by offering more precise and convenient treatment options.
Opportunities
Global healthcare expenditure is rising, driven by increased healthcare access, economic growth, and government initiatives to improve healthcare infrastructure. As a result, more resources are being allocated to diabetes management and treatment, which fuels market growth.
Governments worldwide are implementing initiatives to combat diabetes and its complications. These initiatives include awareness campaigns, early screening programs, reimbursement policies, and incentives for developing and adopting innovative treatments.
Restraints/ Challenges
Diabetes management requires long-term medication, monitoring devices, and insulin therapy, which can be expensive for many patients. The high cost of diabetes treatments can limit access to proper care, particularly in developing countries or for individuals with limited financial resources.
In certain regions, reimbursement policies may not adequately cover the costs associated with diabetes treatments. This can create a barrier for patients to access necessary medications and technologies, leading to suboptimal management of their condition.
This Global diabetes treatments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global diabetes treatments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
The global diabetes treatments market is segmented on the basis of type, product, devices, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Product
Devices
End user
The global diabetes treatments market is analysed and market size insights and trends are provided product type, application, and end user, as referenced above.
The countries covered in the global diabetes treatments market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa.
North America dominates the diabetes treatments market due to major key players, high disposable income, high healthcare expenditure, and well-developed healthcare sector in this region.
Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Global diabetes treatments market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global diabetes treatments market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Global diabetes treatments market. The data is available for historic period 2015-2020.
The Global diabetes treatments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global diabetes treatments market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.